Post-effective amendment to a registration statement that is not immediately effective upon filing

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Cash from operating activities:        
Net Loss $ (3,612,938) $ (1,905,622) $ (2,470,882) $ (1,580,887)
Adjustments to reconcile net loss to net cash used in operating activities:        
Bad debt expense     220,405
Depreciation and amortization 97,353 87,325 184,620 98,922
Stock based compensation 96,270 28,133 44,874 447,826
Modification of employee stock options 102,800    
Interest expense related to debt discounts 94,627 64,652
Amortization of operating lease right of use asset     214,100
Changes in assets and liabilities:        
Accounts receivable 2,114,802 (302,986) (1,293,219) (1,240,489)
Contract assets 530,110 904,543 (167,316) (784,811)
Prepaid expenses and other current assets 235,194 86,411 (174,202) 97,964
Operating lease right of use asset 113,419 (565,925)    
Accounts payable (2,009,394) (519,468) 1,224,720 604,096
Related payable-related party (300) (682) 875
Payroll taxes payable (104,381) (196,609) (202,462) 168,125
Accrued expenses (247,474) 15,671 203,861 (128,948)
Operating lease obligation (114,865) 592,402 (201,761)
Contract liabilities (5,378) (1,170,197) (2,240,168) 2,048,419
Deferred revenue (442,598) 234,988 573,900 (76,379)
Net cash used in operating activities (3,152,753) (2,711,334) (4,019,560) (345,287)
Cash flows from investing activities:        
Software development costs     (60,000)
Purchase of patents/trademarks (7,735) (3,000) (13,095) (13,285)
Purchase of fixed assets (171,467) (223,549) (206,480) (212,393)
Net cash used in investing activities (179,202) (226,549) (219,575) (285,678)
Cash flows from financing activities:        
Repurchase of common stock (1,151) (7,993) (1,459)
Repayments of line of credit (27,615) (2,497) (3,586) (3,312)
Issuance cost (1,001,885) (10,000) (20,000)  
Repayments of notes payable - related parties     (80,000) (48,215)
Repayments of notes payable (1,000,000) (262,500)
Repayments of insurance and equipment financing (83,257) (141,105) (266,134) (243,566)
Payment of finance lease (21,786) (24,652)
Proceeds from SBA loan 1,410,270    
Proceeds from equipment financing 121,637 102,928
Proceeds from notes payable-related parties     1,080,000
Proceeds from notes payable     250,000
Proceeds from common stock issued 9,253,128    
Proceeds from warrants exercised 2,164,019 2,318,020 195,000
Net cash provided by (used in) financing activities 8,650,492 2,009,266 3,086,083 (101,552)
Net increase (decrease) in cash 5,318,537 (928,617) (1,153,052) (732,517)
Cash, beginning of year 56,249 1,209,301 1,209,301 1,941,818
Cash, end of year 5,374,786 280,684 56,249 1,209,301
Supplemental Disclosure of Cash Flow Information:        
Interest paid 29,830 4,109 6,320 7,411
Taxes paid    
Supplemental Non-Cash Investing and Financing Activities:        
Common stock issued for accrued BOD fees 15,000 32,917 73,708
Lease right of use asset and liability 644,245    
Note issued for financing of insurance premiums $ 216,754 $ 217,804    
Common stock issued for accrued officer salary     72,292
Note issued for financing of insurance premiums     260,103 242,239
Debt discount on notes payable     12,500
Note issued for equipment financing lease     55,822
Right of Use Asset and Liability     644,245
Relative fair value of warrant recorded as debt discount     $ 146,779